Best of the Week: October 31 – November 6, 2025 | Cannabis Science and Technology

Let’s dive into the prime tales shaping the dialog this week. Summaries of every article are listed under.

After receiving suggestions from the Virginia Cannabis Control Authority practitioner survey that passed off in the Spring of 2025, the Virginia Cannabis Control Authority (CCA) introduced that the group has shaped a partnership with TheAnswerPage.com. With this partnership, the CCA will be capable of present optionally available on-line coaching for practitioners in order that they could have the instruments that may assist with offering additional affected person care.

“This training empowers practitioners to meet their patients where they are,” said Jamie Patten, Acting Head and Chief Administrative Officer at the CCA. “Patients often come to their doctors with questions about cannabis, but many providers aren’t sure how to respond. This optional course gives them the science-based foundation they need to feel confident in those conversations.”

Our newest Cannabis Analysis column by Brian C. Smith, PhD dives into vital information in the hashish evaluation business.

A coalition of hashish testing labs is suing Revvity Health Sciences (previously PerkinElmer, or PE) for $1 billion, alleging fraud and breach of guarantee. The dispute facilities on PE’s alleged declare that one instrument might precisely analyze the 60+ pesticides required by California legislation, which generally requires two devices. Dr. Smith proposes options like higher compensation for utility scientists and improved lab coaching and regulation.

Explore the full September/October issue of Cannabis Science and Technology here.

On October 20, the New York State Office of Cannabis Management (OCM) launched an announcement declaring it had filed fees in opposition to hashish processor and distributor Omnium Health (Omnium Canna) and had issued a statewide recall of related merchandise. In addition to particulars on the investigation, the OCM additionally launched commentary on its actions.

Felicia A.B. Reid, Acting Executive Director of OCM stated, in part: “Recalling Omnium’s products from dispensaries will present short-term challenges for some retailers and consumers. However, OCM assesses that the impact will likely be modest and fleeting. The long-term outlook for the New York cannabis market remains strong, and OCM expects other licensed and compliant processors—those small businesses marginalized by Omnium’s alleged conduct—to move quickly to fill retail supply gaps.”

Medical hashish proved to be a subject of curiosity for our viewers this week. In the examine, “Symptom management, adherence to therapy, and filling the gaps of medical cannabis therapy: a qualitative study on the importance of nursing consultations for fibromyalgia patients,” researchers aimed to research the function of nurses in therapeutic therapy schooling intervention to bridge data gaps.

“Our findings suggest that patients with FM require specialist clinical advice from initial diagnosis through to the end of treatment, and that nurses with in-depth knowledge of fibromyalgia and treatment options are the best professionals to perform this task; furthermore, healthcare professionals should receive a better education about MC-based treatment regimens,” the researchers said.

Another examine, “Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial,” examined the results of a hashish oil on urge for food, inflammatory markers, and high quality of life in sufferers with systemic sclerosis (SSc) and anorexia or malnutrition.

Overall, the researchers famous potential for future research to substantiate the findings. “Cannabis oil demonstrated a trend toward improving appetite, satisfaction with eating, body weight, daily calorie intake, and quality of life in SSc patients with anorexia or malnutrition,” they said. “While most outcome measures did not reach statistical significance, the treatment group showed a significant increase in hunger VAS scores.”